Research Use Only: For research use only. Not for human consumption. Content is educational and is not medical advice, diagnosis, or treatment.
Peptides / Peptides / Sexual Health

Kisspeptin-10

GPR54 agonist studied for reproductive-axis research

Kisspeptin-10

Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin, studied for its central role in stimulating GnRH release and modulating the hypothalamic-pituitary-gonadal axis.

Typical dose
100–500 mcg per session (research)
Half-life
Short (minutes)
Administration
Subcutaneous injection
Research status
Clinical research (published trials)

What Is Kisspeptin-10?

Kisspeptin-10 is a naturally occurring peptide hormone that plays a central role in regulating the hypothalamic pituitary gonadal (HPG) axis, which governs reproductive function. First identified via the KISS1 gene, it is a key upstream regulator of gonadotropin releasing hormone (GnRH) secretion, with research interest spanning puberty onset, fertility signaling, and broader reproductive endocrine balance.

Mechanisms of Action

  • GnRH secretion via Kiss1 receptor (GPR54) signaling, triggering GnRH release from the hypothalamus and stimulating pituitary output of luteinizing hormone (LH) and follicle stimulating hormone (FSH), supporting ovarian function and sperm production endpoints.

  • Puberty and fertility regulation through control of gonadotropins, influencing puberty onset and downstream reproductive hormone signaling tied to menstrual cycle regulation and testosterone production.

  • Reproductive hormonal balance support by helping maintain appropriate testosterone, estrogen, and progesterone signaling, supporting hormonal homeostasis in both males and females.

Benefits

  • Fertility enhancement research interest, including ovulation induction paradigms in females and spermatogenesis support endpoints in males.

  • Puberty regulation applications in delayed puberty contexts, supporting initiation of pubertal development in models involving hormonal imbalance.

  • Endocrine disorder relevance in research settings such as polycystic ovary syndrome (PCOS) and hypogonadotropic hypogonadism, where restoring hormonal balance is a common target.

Dosing

Strength

Dose

Low

250 to 750 mcg per day

Average

750 to 1500 mcg per day

High

1500 to 5000 mcg per day

Safety Profile

Kisspeptin-10 is generally characterized as well tolerated in clinical studies, with no significant side effects noted in the provided source discussion. Because it directly affects hormonal regulation, it is typically treated as a compound that warrants closer monitoring in endocrine sensitive contexts, including PCOS, hormone sensitive cancers, or other endocrine disorders.

Stacking

Fertility Support Stack

  • Kisspeptin-10

  • HCG

  • HMG

Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.

Where to source